Phathom Pharma provides update on litigation filed by BDR Pharma against FDA
PHAT•BDR Pharmaceuticals has filed suit against the FDA and related federal defendants in U.S. District Court. Phathom Pharmaceuticals said it intends to take appropriate action to protect its statutory exclusivities.
1. Litigation update
BDR Pharmaceuticals has filed suit against the FDA and related federal defendants in U.S. District Court. Phathom Pharmaceuticals said it intends to take appropriate action to protect its statutory exclusivities.
